Breaks Categories: News

ThursdayApr 21, 2022 2:07 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Secures First-Ever Patent for DehydraTECH to Deliver Antiviral Drugs

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its receipt of its first-ever patent for the use of DehydraTECH technology in the enhanced delivery of antiviral drugs. According to the update, Lexaria has received notification from the United States Patent and Trademark Office that patent 11,311,559 for “Compositions and Methods for Enhanced Delivery of Antiviral Agents” will be issued to the company on April 26, 2022. “This will be our 25th patent granted worldwide and another validation of the versatility of our DehydraTECH drug delivery technology,” said Chris Bunka, CEO of Lexaria. “This new…

Continue Reading

ThursdayApr 21, 2022 12:23 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Expansion of Rare Cannabinoid Portfolio

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, is launching business-to-business sales of its rare cannabinoid cannabidivarin (“CBDV”). Through subsidiary BayMedica LLC, InMed will offer its product to wholesalers, suppliers and end-product manufacturers in the health and wellness sector. In addition, the company released a white paper focused on research into the therapeutic potential of CBDV. According to the announcement, CBDV is a nonintoxicating rare cannabinoid that is similar to CBD but offers important differences in activity. One of the most-studied rare cannabinoids, CBDV is currently the focus of several different clinical…

Continue Reading

WednesdayApr 20, 2022 1:22 pm

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Provides Update Regarding Restructuring, Strengthening of Balance Sheet

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, has completed a companywide restricting, which resulted in the elimination of $115 million in liabilities and more than $22 million in annual expenses. Highlights of the strategic moves include the completion of the sale of its Granville, Illinois, facility; the repayment of $51.7 million secured debt and the elimination of $6.3 million of annualized debt servicing; and transitioning to an asset-light, brand-rich model that eliminated more than $13 million in associated annual operating expenses, inclusive of $8 million in cash operating costs. In…

Continue Reading

TuesdayApr 19, 2022 4:37 pm

CannabisNewsBreaks – O’Cannabiz International Conference and Expo Slated for June Return to Toronto

The O’Cannabiz International Conference and Expo is heading back to Toronto this year; the three-day event is scheduled for June 1–3, 2022. The event is designed for cannabis industry entrepreneurs, growers, researchers, suppliers and retailers, as well as cannabis product consumers. Participants will learn about an array of diverse topics covered in more than 70 breakout sessions and workshops and discussed by more than 180 presenters. In addition, the event features a 50,000,000-square-foot expo hall that spotlights hundreds of exhibitors coming from all corners of the cannabis industry. The event networking opportunities are also invaluable. “We’re pleased to announce we’re…

Continue Reading

TuesdayApr 19, 2022 4:22 pm

CannabisNewsBreaks – Organa Kannalytics Releases Dates for 2022 Southeastern Hemp and Medical Cannabis Convention

Organa Kannalytics, an advocacy organization seeking to bring legitimacy to the hemp and medical cannabis industry through science and education, is hosting the upcoming Southeastern Hemp and Medical Cannabis (“SHMC”) Convention. The event is scheduled for May 12–14, 2022, and will be a live event held in Atlanta and streamed online. The event agenda includes inspiring speakers, insightful breakout sessions and invaluable networking opportunities, making this two-day gathering a can’t-miss convention. In-depth discussion will focus on medical use and practices, business opportunities in the hemp and cannabis space, scientific advancements, and local, state and national legislation impacting the growing cannabis…

Continue Reading

TuesdayApr 19, 2022 3:01 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Commences Its Most Comprehensive Study to Date

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has begun its multi-week human clinical hypertension study. The randomized, double blinded, placebo-controlled, cross-over study in 60 people, HYPER-H21-4, is the most comprehensive study ever undertaken by Lexaria. HYPER-H21-4 is designed to enhance Lexaria’s probability of success with its expected subsequent Investigational New Drug (“IND”) application filing to seek U.S. Food and Drug Administration (“FDA”) approval to commence registered clinical testing at phase I level or higher, to be determined in consultation with the FDA. The human study is also expected to enhance Lexaria’s…

Continue Reading

TuesdayApr 19, 2022 12:36 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Upcoming Conferences

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, will be involved in several conferences in April and May. Company management will be participating at the Benzinga Spring Cannabis Capital Conference, scheduled for April 20–21, 2022, in Miami Beach, Florida. InMed executives will be meeting virtually with institutions and industry representatives. Company executives will also be at Canaccord Genuity’s sixth annual Global Cannabis Conference held on May 11, 2022. A recording of the company’s presentation will be available on InMed’s investor relations website following the event. Company leaders will also be available for…

Continue Reading

MondayApr 18, 2022 11:27 am

CannabisNewsBreaks – Advanced Container Technologies Inc. (ACTX) to Attend Benzinga Cannabis Capital Conference

Advanced Container Technologies (OTC: ACTX), which offers a wide array of products including environmentally controlled transportable cultivation systems, unique packaging supplies, in-demand accessories, and white labeling services, today announced that it will attend the Benzinga Cannabis Capital Conference – the leading cannabis-focused investment event in North America. According to the update, the ACTX executive team will connect with the investment community and present its unique value proposition to raise awareness and generate increased interest in the company. “We offer a dynamic product range and are focused on achieving rapid and sustainable growth,” Douglas Heldoorn, CEO of Advanced Container Technologies, said…

Continue Reading

ThursdayApr 14, 2022 12:54 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Positive Results from Pulmonary Hypertension Clinical Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has released data from its HYPER-H21-3 human study. The company noted that data from its simulated pulmonary hypertension clinical study indicate positive safety and efficacy findings. Specifically, results show a tendency (p=0.1) during 15 minutes of simulated low levels of oxygen (hypoxia) for reduced pulmonary artery systolic pressure (“PASP”) with DehydraTECH-CBD treatment versus placebo. According to the announcement, PASP was significantly attenuated by about 5 mmHg or 41% overall (p=0.045) in male participants, which could indicate potential differences by sex in responsiveness to CBD treatment under hypoxic stress conditions. The…

Continue Reading

TuesdayApr 12, 2022 3:07 pm

CannabisNewsBreaks – Organa Kannalytics Announces IBN’s HempWire as Official NewsWire of Southeastern Hemp & Medical Cannabis Convention

Organa Kannalytics has chosen InvestorBrandNetwork’s HempWire brand as an official media sponsor and official NewsWire of the Southeastern Hemp & Medical Cannabis Convention (“SHMC”). The three-day convention is scheduled for May 12–14, 2022, in Atlanta; the event will also be livestreamed. Organa Kannalytics is committed to bringing legitimacy to the hemp and medical cannabis industry by delivering science and education through its premier events. The SHMC expo features breakout sessions covering medical use and practices, business opportunities, the latest in scientific advancements, and local, state and national legislation affecting the cannabis and hemp industries; the event also offers invaluable networking…

Continue Reading